5.40Open6.00Pre Close1 Volume106 Open Interest12.50Strike Price540.00Turnover215.11%IV2.46%PremiumDec 20, 2024Expiry Date4.97Intrinsic Value100Multiplier21DDays to Expiry0.43Extrinsic Value100Contract SizeAmericanOptions Type0.8193Delta0.0293Gamma2.84Leverage Ratio-0.0580Theta0.0047Rho2.33Eff Leverage0.0110Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet